We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.36B
AUM Growth
-$140M
(-5.6%)
Cap. Flow
+$13.2M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
24.15%
Holding
449
New
16
Increased
115
Reduced
93
Closed
20
Top Buys
| 1 |
Boston Beer
SAM
|
+$29.9M |
| 2 |
Becton Dickinson
BDX
|
+$16M |
| 3 |
GFL Environmental
GFL
|
+$11M |
| 4 |
Elanco Animal Health
ELAN
|
+$9.98M |
| 5 |
Netflix
NFLX
|
+$8.85M |
Top Sells
| 1 |
Moderna
MRNA
|
+$30M |
| 2 |
Insulet
PODD
|
+$11M |
| 3 |
Gaotu Techedu
GOTU
|
+$10.4M |
| 4 |
Cloudflare
NET
|
+$9.59M |
| 5 |
Mohawk Industries
MHK
|
+$8.94M |
Sector Composition
| 1 | Consumer Staples | 22.58% |
| 2 | Healthcare | 21% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Communication Services | 9.53% |
| 5 | Materials | 7.76% |
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q3 2021 Portfolio in Review
As of Q3 2021, TOBAM held 449 positions worth $2.36B, down 5.6% from $2.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
TOBAM's Q3 2021 filing shows 16 new, 115 increased, 93 reduced and 20 closed positions. Its largest new stake was DaVita: 8,720 shares worth $1.01M. The largest sale was Moderna, an estimated $30M.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q3 2021 buy was DaVita: 8,720 shares worth $1.01M.
- TOBAM added most to Boston Beer in Q3 2021, an estimated $29.9M increase.
- TOBAM's biggest Q3 2021 reduction was Moderna, cutting an estimated $30M.
- TOBAM fully exited Gaotu Techedu in Q3 2021, selling an estimated $10.4M.
- TOBAM's ten largest holdings make up 24% of its $2.36B portfolio in Q3 2021.
- TOBAM opened 16 new positions and closed 20 in Q3 2021.
- TOBAM's portfolio value fell 5.6% quarter-over-quarter to $2.36B.
Based on TOBAM's 13F filing for Q3 2021, filed 12 Nov 2021.